Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy
- 30 April 1993
- journal article
- clinical trial
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 21 (5), 1094-1100
- https://doi.org/10.1016/0735-1097(93)90230-x
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failureJournal of the American College of Cardiology, 1991
- Long-term (2 year) beneficial effects of beta-adrenergic blockade with bucindolol in patients with idiopathic dilated cardiomyopathyJournal of the American College of Cardiology, 1991
- Effect of beta-adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile, and diastolic performance with bucindolol.Circulation, 1990
- Long-term β-Blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: A double-blind, randomized study of bucindolol versus placeboAmerican Journal Of Medicine, 1990
- Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol.Circulation, 1989
- Nebivolol is devoid of intrinsic sympathomimetic activityEuropean Journal of Pharmacology, 1989
- Cardiovascular effects of dl-nebivolol and its enantiomers — a comparison with those of atenololEuropean Journal of Pharmacology, 1988
- Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic AntagonistJournal of Cardiovascular Pharmacology, 1988
- PROLONGATION OF SURVIVAL IN CONGESTIVE CARDIOMYOPATHY BY BETA-RECEPTOR BLOCKADEThe Lancet, 1979
- Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy.Heart, 1975